Cargando…
Intracellular cGMP increase is not involved in thyroid cancer cell death
INTRODUCTION: Type 5 phosphodiesterase (PDE5) inhibitors (PDE5i) lead to intracellular cyclic-guanosine monophosphate (cGMP) increase and are used for clinical treatment of erectile dysfunction. Studies found that cGMP may up/downregulate the growth of certain endocrine tumor cells, suggesting that...
Autores principales: | Alessandro, Sara D’, Paradiso, Elia, Lazzaretti, Clara, Sperduti, Samantha, Perri, Carmela, Antoniani, Francesco, Righi, Sara, Simoni, Manuela, Brigante, Giulia, Casarini, Livio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062617/ https://www.ncbi.nlm.nih.gov/pubmed/36996255 http://dx.doi.org/10.1371/journal.pone.0283888 |
Ejemplares similares
-
MON-486 Polygenic Susceptibility to Papillary Thyroid Cancer in Italian Subjects
por: Brigante, Giulia, et al.
Publicado: (2020) -
Allosteric modulation of gonadotropin receptors
por: Lazzaretti, Clara, et al.
Publicado: (2023) -
FSH for the Treatment of Male Infertility
por: Casarini, Livio, et al.
Publicado: (2020) -
The “Hitchhiker’s Guide to the Galaxy” of Endothelial Dysfunction Markers in Human Fertility
por: Santi, Daniele, et al.
Publicado: (2021) -
Identification of Key Receptor Residues Discriminating Human Chorionic Gonadotropin (hCG)- and Luteinizing Hormone (LH)-Specific Signaling
por: Lazzaretti, Clara, et al.
Publicado: (2020)